Ijzer (Iii)carboxymaltose

Iron, the active ingredient in Ijzer (Iii)carboxymaltose, is an iron supplement presented as an intravenous solution for intravenous use. It treats iron deficiency anemia in adults and in patients with chronic kidney disease or peri‑operative blood loss.

GNH USA supplies Ijzer (Iii)carboxymaltose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ijzer (Iii)carboxymaltose is used to correct iron deficiency in several clinical settings. - Iron deficiency anemia: restores hemoglobin levels and alleviates fatigue. - Anemia associated with chronic kidney disease: provides rapid iron repletion to support erythropoiesis. - Perioperative anemia management: reduces the need for blood transfusion before or after surgery.

Adverse reactions may occur with intravenous iron administration.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Headache: transient pain often resolving without intervention. - Injection site reactions: redness, swelling or pain at the infusion site. - Dizziness: temporary light‑headedness during or after infusion. - Flushing: brief warmth or redness of the skin. - Hypotension: mild drop in blood pressure shortly after dosing.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: marked blood pressure decline that may need intervention. - Iron overload: excessive iron accumulation leading to organ damage. - Acute respiratory distress: sudden breathing difficulty. - Cardiac arrhythmia: irregular heart rhythm observed in rare cases. - Hepatic injury: liver enzyme elevations indicating possible liver stress.

Before using Ijzer (Iii)carboxymaltose, consider the following safety measures. - Assess iron status: confirm iron deficiency with laboratory tests before infusion. - Monitor during infusion: observe vital signs and watch for hypersensitivity reactions. - Caution in renal impairment: adjust monitoring as reduced clearance may affect iron handling. - Avoid in active infection: defer treatment until infection is controlled. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous iron can interact with certain medications and substances.

Major Interactions (Avoid): - Concurrent IV iron products: may cause iron overload. - High‑dose vitamin C administered intravenously: can increase free iron and risk oxidative injury.

Moderate Interactions (Monitor Closely): - Erythropoiesis‑stimulating agents: may amplify hemoglobin rise, requiring dose adjustment. - Antacids or oral chelators given close to infusion: could alter iron distribution. - Certain antibiotics (e.g., tetracyclines): may bind iron and reduce efficacy. - Blood pressure‑lowering agents: monitor for additive hypotensive effect.